PT1113797E - Utilização da duloxetina para o tratamento da fibromialgia - Google Patents

Utilização da duloxetina para o tratamento da fibromialgia Download PDF

Info

Publication number
PT1113797E
PT1113797E PT99969026T PT99969026T PT1113797E PT 1113797 E PT1113797 E PT 1113797E PT 99969026 T PT99969026 T PT 99969026T PT 99969026 T PT99969026 T PT 99969026T PT 1113797 E PT1113797 E PT 1113797E
Authority
PT
Portugal
Prior art keywords
duloxetine
fibromyalgia
treatment
naphthalenyloxy
propanamine
Prior art date
Application number
PT99969026T
Other languages
English (en)
Inventor
Smriti Iyengar
David Joel Goldstein
Rosa Marie Ademe Simmons
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PT1113797E publication Critical patent/PT1113797E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT99969026T 1998-09-15 1999-09-10 Utilização da duloxetina para o tratamento da fibromialgia PT1113797E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10037798P 1998-09-15 1998-09-15

Publications (1)

Publication Number Publication Date
PT1113797E true PT1113797E (pt) 2009-12-21

Family

ID=22279434

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99969026T PT1113797E (pt) 1998-09-15 1999-09-10 Utilização da duloxetina para o tratamento da fibromialgia

Country Status (15)

Country Link
US (1) US6596756B1 (pt)
EP (1) EP1113797B1 (pt)
JP (1) JP2002524513A (pt)
CN (1) CN1149991C (pt)
AT (1) ATE449603T1 (pt)
AU (1) AU746887B2 (pt)
BR (1) BR9913671A (pt)
CA (1) CA2344057C (pt)
CY (1) CY1110581T1 (pt)
DE (1) DE69941712D1 (pt)
DK (1) DK1113797T3 (pt)
ES (1) ES2335067T3 (pt)
PT (1) PT1113797E (pt)
SI (1) SI1113797T1 (pt)
WO (1) WO2000015223A1 (pt)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030087938A1 (en) * 2001-07-31 2003-05-08 Robertson David W. Treatment of chronic pain with 3-heterocycloxy-and 3-cycloalkyloxy-3-phenylpropanamines
US6602911B2 (en) * 2001-11-05 2003-08-05 Cypress Bioscience, Inc. Methods of treating fibromyalgia
AU2003225206B2 (en) * 2002-04-24 2008-02-14 Forest Laboratories Holdings Limited Prevention and treatment of functional somatic disorders, including stress-related disorders
AU2003227519A1 (en) * 2002-05-30 2003-12-19 Head Explorer A/S The use of milnacipran for the treatment of tension-type headache
CN1678322A (zh) * 2002-08-29 2005-10-05 阿瑞科诺沃治疗有限公司 (4－(2－氟苯基)－6－甲基－2－(1－哌嗪基)噻吩并[2,3－d]嘧啶的新治疗用途
EP1565182A1 (en) * 2002-11-19 2005-08-24 Eli Lilly And Company Treatment of gastrointestinal disorders with duloxetine
US20100256179A1 (en) * 2004-03-26 2010-10-07 Ucb Pharma Gmbh Combination therapy for pain in painful diabetic neuropathy
US20050233980A1 (en) * 2004-04-20 2005-10-20 Boehringer Ingelheim International Gmbh CGRP-antagonist in combination with a serotonin-reuptake inhibitor for the treatment of migraine
CA2573122A1 (en) * 2004-07-24 2006-02-02 Laboratorios Del Dr. Esteve, S.A. Use of compounds active on the sigma receptor for the treatment of mechanical allodynia
CN100362996C (zh) * 2004-10-14 2008-01-23 上海医药工业研究院 一种度洛西汀肠溶微丸胶囊及其制备方法
JP2007523213A (ja) * 2004-12-23 2007-08-16 テバ ファーマシューティカル インダストリーズ リミティド 医薬的に許容できるデュロキセチンの塩及びその中間体の調製方法
EP1856087A1 (en) * 2005-03-08 2007-11-21 Teva Pharmaceutical Industries Limited Crystal forms of (s)-(+)-n,n-dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl) propanamine oxalate and the preparation thereof
WO2007005644A2 (en) * 2005-07-01 2007-01-11 Concert Pharmaceuticals Inc. Novel aryloxypropanamines
EP1754476A1 (en) * 2005-08-18 2007-02-21 Schwarz Pharma Ag Lacosamide (SPM 927) for treating myalgia, e.g. fibromyalgia
WO2007062119A1 (en) * 2005-11-23 2007-05-31 Auspex Pharmaceuticals, Inc. Substituted aryloxypropylamines with serotoninergic and/or norepinephrinergic activity
MX2008001079A (es) * 2006-05-23 2008-03-19 Teva Pharma Polimorfos de hidrocloruro de duloxetina.
EA027836B1 (ru) 2006-06-15 2017-09-29 ЮСиБи ФАРМА ГМБХ Фармацевтическая комбинация для профилактики, облегчения и/или лечения приступов эпилепсии и ее применение
WO2008009665A1 (en) * 2006-07-19 2008-01-24 Boehringer Ingelheim International Gmbh Treatment of pain
TW200846003A (en) * 2007-03-15 2008-12-01 Astellas Pharma Inc Novel prophylactic and/or therapeutic agent for diabetic neuropathy
US8708961B2 (en) * 2008-01-28 2014-04-29 Medsolve Technologies, Inc. Apparatus for infusing liquid to a body
US8758779B2 (en) 2009-06-25 2014-06-24 Wockhardt Ltd. Pharmaceutical composition of duloxetine
HUE042593T2 (hu) * 2010-03-09 2019-07-29 Alkermes Pharma Ireland Ltd Alkoholnak ellenálló enterális gyógyszerkészítmények
TW201615191A (zh) * 2014-10-24 2016-05-01 朗齊生物醫學股份有限公司 氨氯地平藥物應用於癌症治療
JP2020029447A (ja) * 2018-06-25 2020-02-27 大原薬品工業株式会社 腸溶性高分子及び抗付着剤を含有する顆粒
JP7390830B2 (ja) * 2019-09-11 2023-12-04 日本食品化工株式会社 医薬活性化合物の苦味抑制剤及び苦味抑制方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4956388A (en) 1986-12-22 1990-09-11 Eli Lilly And Company 3-aryloxy-3-substituted propanamines
CA2134038C (en) * 1994-06-16 1997-06-03 David Taiwai Wong Potentiation of drug response
US5508276A (en) 1994-07-18 1996-04-16 Eli Lilly And Company Duloxetine enteric pellets
ZA958725B (en) 1994-10-20 1997-04-16 Lilly Co Eli Treatment of disorders with duloxetine
RO117296B1 (ro) 1996-03-11 2002-01-30 Lilly Co Eli Metoda pentru tratarea sau prevenirea cistitei interstitiale
UA48219C2 (uk) * 1996-03-25 2002-08-15 Елі Ліллі Енд Компані Композиція для вгамування болю (варіанти) та спосіб вгамування болю
US5912256A (en) * 1996-06-20 1999-06-15 Eli Lilly And Company Compounds having effects on serotonin-related systems

Also Published As

Publication number Publication date
US6596756B1 (en) 2003-07-22
EP1113797B1 (en) 2009-11-25
WO2000015223A1 (en) 2000-03-23
EP1113797A4 (en) 2006-07-05
AU746887B2 (en) 2002-05-02
CN1149991C (zh) 2004-05-19
EP1113797A1 (en) 2001-07-11
CN1316904A (zh) 2001-10-10
ES2335067T3 (es) 2010-03-18
ATE449603T1 (de) 2009-12-15
CA2344057C (en) 2008-11-18
AU1197200A (en) 2000-04-03
BR9913671A (pt) 2001-06-05
JP2002524513A (ja) 2002-08-06
DE69941712D1 (de) 2010-01-07
CA2344057A1 (en) 2000-03-23
DK1113797T3 (da) 2010-02-01
SI1113797T1 (sl) 2010-02-26
CY1110581T1 (el) 2015-04-29

Similar Documents

Publication Publication Date Title
SI1113797T1 (sl) Uporaba duloksetina pri zdravljenju fibromialgije
JP2002524513A5 (pt)
UA42716C2 (uk) ГЕМІСОЛЬВАТИ 6-ГІДРОКСИ-2-(4-ГІДРОКСИФЕНІЛ)-3-[4-(ПІПЕРИДИНОЕТОКСИ)БЕНЗОЇЛ]БЕНЗО[b]ТІОФЕНГІДРОХЛОРИДУ
TR200000755T2 (tr) Karşıt olma-karşı gelme bozukluğunun tedavisi.
HUP0004025A3 (en) Treatment of conduct disorder using norepinephrine reuptake inhibitors
NO2008014I1 (no) Rotigotin (c)-5,6,7,8-tetrahydro-6-(propyl(2,2-tienyl)amino)-1-naftol
FR12C0052I2 (fr) Utilisation de dapoxetine, un inhibiteur selectif de recaptage de serotonine a action rapide, pour traiter un dysfonctionnement sexuel
NO993246D0 (no) Engangs, elastisk varmeavgivende ryggbandasje, samt fremgangsmÕte ved behandling av ryggsmerter
HK90197A (en) Improvements in or relating to benzothiophenes
AU6530600A (en) Use of neurotoxin for treating cardiac muscle disorders
ZA958725B (en) Treatment of disorders with duloxetine
EP0756869A3 (en) Use of duloxetine or of N-alkyl-3-phenyl-(2-alkylthiophenoxy)-propylamines for treating attention-deficit/hyperactivity disorder
HUP9902884A2 (en) Use of duloxetine for treating or preventing interstitial cystitis
WO2001066101A3 (en) Treatment of psoriasis
AU2002347984A1 (en) Use of norepinephrine reuptake inhibitors for the treatment of tic disorders
ATE226825T1 (de) Behandlung der anorexie
IL126158A0 (en) Method for treating substance abuse
AP2000002002A0 (en) Method of treatment.
ZA200007494B (en) Use of inhibitors of protein kinase C epsilon to treat pain.
MX9909548A (es) Metodos para la reduccion de fibrinogenos.